Enliven Therapeutics (ELVN) PT Lowered to $78 at Guggenheim
Tweet Send to a Friend
(Updated - August 6, 2026 7:39 AM EDT)
Guggenheim analyst Michael Schmidt lowered the price target on Enliven Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Michael Schmidt lowered the price target on Enliven Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
